1200 Pharma Stock

Breakthrough medicinal chemistry technology to dramatically accelerate pre-clinical drug discovery and clinical approval timelines.

Sign up today and learn more about 1200 Pharma Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About 1200 Pharma Stock

1200 Pharma uses breakthrough medicinal chemistry technology from Caltech and proprietary biomarker-driven assays from UCLA to dramatically accelerate pre-clinical drug discovery and clinical approval timelines.

Funding History

November 2017$6.2M
November 2019$5.5M

Management

President & CEO

David Licata

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo